Many prescriptions are allowed, with conditions. The federal rules ban Schedule I drugs outright, allow other controlled substances such as Adderall, tramadol or Xanax only when a licensed practitioner who knows your medical history prescribed the drug and has advised you it will not affect safe driving, and leave everything else to the medical examiner's judgement about your condition and the drug's side effects. The certified medical examiner makes the call at your DOT physical; nothing on this page replaces that.
The three tiers in the rule
Two rules say almost the same thing, one for the medical card and one for being on duty:
- 49 CFR 391.41(b)(12)(i): to be physically qualified a person must not use any Schedule I substance (21 CFR 1308.11), an amphetamine, a narcotic or other habit-forming drug. 391.41(b)(12)(ii): a person must not use any non-Schedule I substance in the other schedules of 21 CFR Part 1308 except when prescribed by a licensed medical practitioner, as defined in 382.107, who is familiar with the driver's medical history and has advised the driver that the substance will not adversely affect the ability to drive a CMV safely.
- 49 CFR 382.213(a) and (b) apply the same Schedule I ban and the same prescription exception to reporting for or staying on duty. Under 382.213(c) an employer who knows a driver has used a controlled substance may not let the driver work unless that exception is met, and under 382.213(d) an employer may require drivers to tell it about therapeutic drug use.
Read together, and with paragraph J.2 of the Medical Advisory Criteria (Appendix A to Part 391, January 2024), the rule works in three tiers:
| Tier | Examples | What the rule allows |
|---|---|---|
| Schedule I (21 CFR 1308.11) | Heroin, LSD, psilocybin, marijuana outside FDA-approved or state-medical-licensed forms | Never. Paragraph J.1: Schedule I drugs cannot be prescribed for any purpose, so the examiner cannot qualify a user. |
| Schedules II to V (21 CFR 1308.12 to 1308.15) | Amphetamine, opioids, benzodiazepines, sleep drugs, some anticonvulsants | Only under the prescription exception. Paragraph J.2 confirms an examiner may qualify a driver using an amphetamine, a narcotic or another Schedule II to V drug if the exception is met. |
| Not in 21 CFR Part 1308 | For example sertraline, rivaroxaban, gabapentin, tirzepatide, insulin | Not covered by (b)(12). The examiner judges the underlying condition and side effects under the other standards. |
Where common drugs sit
The table checks each drug against the text of 21 CFR Part 1308 in the eCFR as of 23 September 2026. "DOT analyte" means the drug is one of the substances the laboratory looks for under 49 CFR 40.85. Brand names are given for recognition only.
| Drug (brand) | Federal schedule | DOT analyte? |
|---|---|---|
| Amphetamine salts (Adderall) | II (1308.12(d)) | Yes, amphetamine |
| Lisdexamfetamine (Vyvanse) | II (1308.12(d)) | Not listed by name |
| Methylphenidate (Ritalin) | II (1308.12(d)) | No |
| Hydrocodone, oxycodone, codeine | II (1308.12) | Yes |
| Buprenorphine | III (1308.13) | No |
| Tramadol (Ultram) | IV (1308.14) | No |
| Alprazolam (Xanax), diazepam, lorazepam, clonazepam | IV (1308.14) | No |
| Zolpidem (Ambien) | IV (1308.14) | No |
| Modafinil, phentermine | IV (1308.14) | No |
| Pregabalin (Lyrica) | V (1308.15) | No |
| Gabapentin (Neurontin) | Not in Part 1308 | No |
| Sertraline (Zoloft) | Not in Part 1308 | No |
| Rivaroxaban (Xarelto) | Not in Part 1308 | No |
| Tirzepatide (Zepbound), semaglutide | Not in Part 1308 | No |
| Insulin | Not in Part 1308 | No, but see 391.46 |
Two cautions. "Not a DOT analyte" only means the laboratory is not looking for it; it says nothing about whether the drug is allowed. And Part 1308 is the federal list; this page does not cover state scheduling.
Meeting the prescription exception
The exception has four parts, and all four have to be true:
- Prescribed. Someone else's pills, or leftovers from an old prescription for a different problem, do not qualify.
- By a licensed medical practitioner, which 382.107 defines as a person licensed, certified or registered under federal, state, local or foreign law to prescribe controlled substances and other drugs.
- Who is familiar with your medical history. An urgent care visit with no records may not meet this.
- Who has advised you that the drug will not adversely affect your ability to drive a CMV safely.
Paragraph J.3 of the Medical Advisory Criteria says one way for the examiner to confirm this is to ask for a written note from the prescriber, and that FMCSA publishes a voluntary form for it, the 391.41 CMV Driver Medication Form, MCSA-5895, which may be used with the driver's consent. Bringing it completed to the exam saves a pending determination.
Opioids, and the word "narcotic"
Read on its own, 391.41(b)(12)(i) looks like a flat ban on "an amphetamine, a narcotic, or other habit-forming drug". Paragraph J.2 of the Medical Advisory Criteria explains how FMCSA reads it with (b)(12)(ii): an examiner may qualify a driver who uses an amphetamine, a narcotic or another drug in Schedules II to V if the prescription exception is met. So a short course of a prescribed opioid after surgery is not automatically disqualifying. The examiner will still weigh sedation, the reason for the prescription, and how long it will last, and may certify for a shorter period.
The same logic covers medicines for opioid use disorder. Methadone is Schedule II (1308.12) and buprenorphine is Schedule III (1308.13), so both go through the prescription exception. Neither appears among the analytes in 40.85, so a routine DOT test does not look for them. The examiner decides, looking at the treatment and the history behind it.
Sleep medicines and wake-promoting drugs
Drivers on irregular schedules ask about both ends. Zolpidem is Schedule IV, and so is modafinil (1308.14). Both need the prescription exception. Neither is a DOT analyte. The practical rule for both is 392.3: a driver must not start or continue driving while alertness is impaired, or likely to become impaired, through fatigue, illness or any other cause. A sleeping pill taken too close to a shift, or a stimulant used to push past the hours limits, creates exactly the problem that rule is aimed at. The hours limits themselves are on the hours of service page, and sleep disorders are covered on sleep apnea and the DOT physical.
Non-controlled drugs: the condition matters more
Many common drugs are not controlled substances, and 391.41(b)(12) does not apply to them. The examiner still considers it under the standard for the condition being treated. The Medical Advisory Criteria give several examples:
- Blood thinners. Paragraph C.3: anticoagulation should not, by its use alone, preclude certification; the emphasis is on the underlying condition.
- Blood pressure drugs. Paragraph E.7: most antihypertensives have side effects such as somnolence or syncope, which must be evaluated individually. See blood pressure limits.
- Psychiatric drugs. Paragraph H.4: careful consideration should be given to side effects and interactions, because medications for mental, nervous, organic or functional disease may be likely to interfere with safe driving.
- Anti-seizure drugs. Paragraph G.1: a person taking antiseizure medication to prevent seizures is not physically qualified. The paragraph turns on the purpose of the drug, so tell the examiner why you take each one.
- Insulin. Covered by its own section, 391.46. See diabetes, insulin and the CDL.
On the road, two more rules apply to any medicine. 392.3 bars driving while ability or alertness is so impaired, or so likely to become impaired, through illness or any other cause that it is unsafe. 392.4(a)(4) bars being on duty under the influence of any substance to a degree that makes you incapable of safe driving. And 382.107 defines alcohol use to include swallowing any medication containing alcohol, so an alcohol-based cough syrup counts under the four-hour rule in 382.207 and 392.5(a)(1).
What happens at a drug test if you take a prescribed controlled drug
If your prescription is one of the DOT analytes, such as amphetamine or oxycodone, the laboratory will report it. The Medical Review Officer then interviews you. Under 40.137(a) the MRO verifies the result negative if you present a legitimate medical explanation, and in judging a legally valid prescription consistent with the Controlled Substances Act the MRO must not question whether the doctor should have prescribed it. Under 40.141(b) the MRO checks the prescription, and may call your doctor or pharmacy.
A negative verification is not the end of it. Under 40.135(e) the MRO must tell you that before reporting a safety concern about a legally prescribed drug to anyone, you get 5 business days from the verified negative for your prescriber to contact the MRO about switching to a drug that does not raise the concern. If the concern remains, 40.327 requires the MRO to report it, without your consent, to the employer or to the examiner responsible for your medical qualification, among others. Do not list medications on the custody and control form; 40.61(g) says the collector must tell you not to. They are for the MRO.
Medications bought abroad are handled by 40.137(e): they can be a legitimate explanation only if obtained legally in that country, with a legitimate medical use, and used as intended.
Example: tramadol after a back injury
Illustration of the rules, not medical advice. A driver hurts his back unloading and an urgent care doctor prescribes tramadol, a Schedule IV drug. Three separate rules are now in play. First, 391.45(g) requires a new medical examination for any driver whose ability to perform normal duties has been impaired by an injury, whatever the date on the card. Second, to drive while taking tramadol he needs the prescription exception in 382.213(b): the urgent care doctor has no knowledge of his history, so he asks his regular doctor, who knows it, to review the prescription and, if appropriate, complete an MCSA-5895 stating the drug will not affect his driving. Third, tramadol is not a DOT analyte, so a random test would not report it; that is irrelevant to whether he may drive on it. The examiner, with the form and his history, decides whether and for how long to certify him.
Before your physical: a medication checklist
None of this is required by the rule in these words, but each item maps to something the examiner or the MRO will ask:
- Write every prescription, over-the-counter drug, herbal remedy and supplement you take, with the dose. Section 1 of the MCSA-5875 asks for all of them.
- For each controlled drug, get a note from the prescriber who knows your history, saying you drive a commercial vehicle and the drug will not adversely affect that. The MCSA-5895 is one format.
- Know why you take each drug, especially anything that is also used for seizures, mood or sleep.
- If a new drug started after an injury or a new diagnosis, check whether 391.45(g) already requires a new exam.
- Keep the pharmacy label or prescription record where you can find it quickly. After a non-negative test, the MRO interview is where it counts, and 40.137(c) puts the burden of proof on you.
Mistakes that end careers
- Taking a spouse's or friend's prescription. It is not "prescribed" to you, so the exception cannot apply, and if it is an analyte there is no legitimate medical explanation.
- Relying on "the MRO cleared me". A verified negative is about the test; fitness is separate under 40.327 and the medical standards.
- Leaving drugs off the MCSA-5875. The form asks about prescription and over-the-counter drugs, herbal remedies and supplements, and you certify the list.
- Never telling the prescriber you drive a truck. The exception requires the prescriber's advice about CMV driving specifically.
- Assuming a non-tested drug is safe. 392.3 and 392.4(a)(4) apply to anything that impairs.
When you are ready to book, the DOT physical directory lists certified examiners by city, and what happens at a DOT physical explains the visit.